- Home
- NKTX vs NCT Comparison
NKTX vs NCT Comparison
Compare NKTX & NCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- NCT
- Stock Information
- Founded
- NKTX 2015
- NCT 2011
- Country
- NKTX United States
- NCT Hong Kong
- Employees
- NKTX N/A
- NCT N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- NCT
- Sector
- NKTX Health Care
- NCT
- Exchange
- NKTX Nasdaq
- NCT NYSE
- Market Cap
- NKTX 123.5M
- NCT 116.0M
- IPO Year
- NKTX 2020
- NCT 2025
- Fundamental
- Price
- NKTX $1.74
- NCT $3.99
- Analyst Decision
- NKTX Strong Buy
- NCT
- Analyst Count
- NKTX 6
- NCT 0
- Target Price
- NKTX $14.80
- NCT N/A
- AVG Volume (30 Days)
- NKTX 422.6K
- NCT 75.1K
- Earning Date
- NKTX 05-14-2025
- NCT 01-01-0001
- Dividend Yield
- NKTX N/A
- NCT N/A
- EPS Growth
- NKTX N/A
- NCT N/A
- EPS
- NKTX N/A
- NCT 0.13
- Revenue
- NKTX N/A
- NCT $25,526,936.00
- Revenue This Year
- NKTX N/A
- NCT N/A
- Revenue Next Year
- NKTX N/A
- NCT N/A
- P/E Ratio
- NKTX N/A
- NCT $31.28
- Revenue Growth
- NKTX N/A
- NCT N/A
- 52 Week Low
- NKTX $1.31
- NCT $3.05
- 52 Week High
- NKTX $8.23
- NCT $8.76
- Technical
- Relative Strength Index (RSI)
- NKTX 45.11
- NCT N/A
- Support Level
- NKTX $1.70
- NCT N/A
- Resistance Level
- NKTX $1.82
- NCT N/A
- Average True Range (ATR)
- NKTX 0.10
- NCT 0.00
- MACD
- NKTX -0.01
- NCT 0.00
- Stochastic Oscillator
- NKTX 18.82
- NCT 0.00
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About NCT INTERCONT (CAYMAN) LIMITED
Intercont (Cayman) Ltd operates through its subsidiaries. It is principally engaged in the time charter service and vessel management services business.